The legacy success of copyright’s flagship drug has undeniably transformed the pharmaceutical landscape. However, putting money in companies heavily dependent on copycat drugs and the diminishing patent https://socialtechnet.com/story6953052/the-blue-pill-and-pharmaceutical-companies-a-uncertain-investment